Sunitinib may raise the risk of bisphosphonate-related osteonecrosis of the jaw: Presentation of three cases

Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology and Endodontology

Volumn 110, Issue 4, 2010, Pages 463-469

  Hoefert, Sebastian ^a   Eufinger, Harald ^a  

^a RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BISPHOSPHONIC ACID DERIVATIVE; BONE DENSITY CONSERVATION AGENT; INDOLE DERIVATIVE; PROTEIN KINASE INHIBITOR; PROTEIN TYROSINE KINASE; PYRROLE DERIVATIVE; SUNITINIB;

ARTICLE; BONE NECROSIS; CASE REPORT; CHEMICALLY INDUCED DISORDER; DRUG ANTAGONISM; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; JAW DISEASE; KIDNEY CARCINOMA; KIDNEY TUMOR; MIDDLE AGED; MUCOSA INFLAMMATION; RISK FACTOR; STOMATITIS; TOOTH EXTRACTION;

ANTINEOPLASTIC AGENTS; BONE DENSITY CONSERVATION AGENTS; CARCINOMA, RENAL CELL; DIPHOSPHONATES; HUMANS; INDOLES; INJECTIONS, INTRAVENOUS; KIDNEY NEOPLASMS; MANDIBULAR DISEASES; MIDDLE AGED; MUCOSITIS; OSTEONECROSIS; PROTEIN KINASE INHIBITORS; PROTEIN-TYROSINE KINASES; PYRROLES; RISK FACTORS; STOMATITIS; TOOTH EXTRACTION;

EID: 77957111700     PISSN: 10792104     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tripleo.2010.04.049     Document Type: Article

References (18)

1. R.E. Marx Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic J Oral Maxillofac Surg 61 2003 1115 1117
2. J. Sarin, S.S. DeRossi, and S.O. Akintoye Updates on bisphosphonates and potential pathobiology of bisphosphonate-induced jaw osteonecrosis Oral Dis 14 2008 277 285
3. S.L. Ruggiero, T.B. Dodson, L.A. Assael, R. Landesberg, R.E. Marx, and B. Mehrotra American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws2009 update J Oral Maxillofac Surg 67 2009 2 12
4. M.R. Allen, and D.B. Burr The pathogenesis of bisphosphonate-related osteonecrosis of the jaw: so many hypotheses, so few data J Oral Maxillofac Surg 67 2009 61 70
5. S.L. Ruggiero, and S.J. Drew Osteonecrosis of the jaws and bisphosphonate therapy J Dent Res 86 2007 1013 1021
6. T. Yoneda, H. Hagino, T. Sugimoto, H. Ohta, S. Takahashi, and S. Soen Bisphosphonate-related osteonecrosis of the jaw: position paper from the Allied Task Force Committee of Japanese Society for Bone and Mineral Research, Japan Osteoporosis Society, Japanese Society of Periodontology, Japenese Society for Oral and Maxillofacial Radiology, and Japanese Society of Oral and Maxillofacial Surgeons J Bone Miner Metab 28 2010 365 383
7. D.K. Lam, G.K. Sandor, H.I. Holmes, A.W. Evans, and C.M. Clokie A review of bisphosphonate- associated osteonecrosis of the jaws and its management J Can Dent Assoc 73 2007 417 422
8. E.P. Rock, V. Goodman, J.X. Jiang, K. Mahjoob, S.L. Verbois, and D. Morse Food and Drug Administration drug approval summary: Sunitinib malate for the treatment of gastrointestinal stromal tumor and advanced renal cell carcinoma Oncologist 12 2007 107 113 (Pubitemid 46143508)
9. M.D. Mignogna, G. Fortuna, S. Leuci, A. Pollio, and E. Ruoppo Sunitinib adverse event: oral bullous and lichenoid mucositis Ann Pharmacother 43 2009 546 547
10. C. Kollmannsberger, D. Soulieres, R. Wong, A. Scalera, R. Gaspo, and G. Bjarnason Sunitinib therapy for metastatic renal cell carcinoma: recommendations for management of side effects Can Urol Assoc J 1 2007 41 54
11. S.E. Rosenbaum, S. Wu, M.A. Newman, D.P. West, T. Kuzel, and M.E. Lacouture Dermatological reactions to the multitargeted tyrosine kinase inhibitor sunitinib Support Care Cancer 16 2008 557 566
12. P. Lesclous, S.A. Najm, J.P. Carrel, B. Baroukh, T. Lombardi, and J.P. Willi Bisphosphonate-associated osteonecrosis of the jaw: a key role of inflammation? Bone 45 2009 843 852
13. R.J. Motzer, T.E. Hutson, P. Tomczak, M.D. Michaelson, R.M. Bukowski, and S. Oudard Overall survival and updated results for sunitinib compared with interferon alpha in patients with metastatic renal cell carcinoma J Clin Oncol 27 2009 3584 3590
14. A. Brunello, G. Saia, A. Bedogni, D. Scaglione, and U. Basso Worsening of osteonecrosis of the jaw during treatment with sunitinib in a patient with metastatic renal cell carcinoma Bone 44 2009 173 175
15. P. Suwattee, S. Chow, B.C. Berg, and E.M. Warshaw Sunitinib: a cause of bullous palmoplantar erythrodysesthesia, periungual erythema, and mucositis Arch Dermatol 144 2008 123 125
16. M.R. Allen, D.J. Kubek, and D.B. Burr Cancer treatment dosing regimens of zoledronic acid result in near complete suppression of mandible intra-cortical bone remodeling in beagle dogs J Bone Miner Res 25 2010 98 105
17. M.R. Allen, and D.B. Burr Mandible matrix necrosis in beagle dogs after 3 years of daily oral bisphosphonate treatment J Oral Maxillofac Surg 66 2008 987 994
18. C.L. Estilo, M. Fornier, A. Farooki, D. Carlson, G. Bohle, and J.M. Huryn Osteonecrosis of the jaw related to bevacizumab J Clin Oncol 26 2008 4037 4038